Liver-to-Plasma Vaniprevir (MK-7009) Concentration Ratios in HCV-Infected Patients - Concepedia

Concepedia

Publication | Open Access

Liver-to-Plasma Vaniprevir (MK-7009) Concentration Ratios in HCV-Infected Patients

DOI Full Paper Access

14

Citations

11

References

2014

Year

D. Hamish Wright, Luzelena Caro, Michael Cerra, Paul Panorchan, Lihong Du, Melanie Anderson, Andrej Potthoff, Robert B. Nachbar, John A. Wagner, Michael P. Manns,

Antiviral Therapy

Abstract

These data confirm higher vaniprevir concentrations in human liver compared with plasma and demonstrate that measurement of human liver drug concentration using needle biopsy is feasible.

References

	Year	Citations
Preclinical Profile of VX-950, a Potent, Selective, and Orally Bioavailable Inhibitor of Hepatitis C Virus NS3-4A Serine Protease Robert B. Perni, Susan J. Almquist, Randal A. Byrn, Antimicrobial Agents and Chemotherapy	2006	382
Discovery of Vaniprevir (MK-7009), a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor John A. McCauley, Charles McIntyre, Michael T. Rudd, Journal of Medicinal Chemistry ImmunologyAntiviral DrugMedicinal ChemistryViral HepatitisAntiviral Drug Development	2010	176
MK-7009, a Potent and Selective Inhibitor of Hepatitis C Virus NS3/4A Protease Nigel J. Liverton, Steven S. Carroll, Jillian DiMuzio, Antimicrobial Agents and Chemotherapy ImmunologyMolecular BiologyAntiviral DrugExcellent SelectivityViral Hepatitis	2009	141
Comparison of techniques for extraction of isoflavones from the root of Radix Puerariae: Ultrasonic and pressurized solvent extractions Mi‐Jung Lee, Chiu‐Yue Lin Food Chemistry Food ChemistrySolvent ExtractionPressurized Solvent ExtractionsBioassay-guided IsolationRadix Puerariae	2006	93
Vaniprevir with pegylated interferon alpha-2a and ribavirin in treatment-naïve patients with chronic hepatitis C: A randomized phase II study Michael P. Manns, Edward Gane, M. Rodríguez‐Torres, Hepatology	2012	57
Pharmacokinetic/Pharmacodynamic Predictors of Clinical Potency for Hepatitis C Virus Nonnucleoside Polymerase and Protease Inhibitors Micaela B. Reddy, Peter N. Morcos, Sophie Le Pogam, Antimicrobial Agents and Chemotherapy	2012	43
Ultrasound assisted extraction in quantifying lutein from chicken liver using high-performance liquid chromatography☆ Ting Sun, Zhihong Xu, J. Samuel Godber Journal of Chromatography B EngineeringHepatologyLiver PhysiologyPathologyHigh-performance Liquid Chromatography☆	2005	25
Liver Damage Induced by Bile Duct Ligation Affects CYP Isoenzymes Differently in Rats Tomonori Tateishi, Minoru Watanabe, Hironori Nakura, Pharmacology & Toxicology	1998	22
Telaprevir‐based treatment effects on hepatitis C virus in liver and blood Andrew H. Talal, Rositsa B. Dimova, Eileen Z. Zhang, Hepatology	2014	21
The metabolism and disposition of a potent inhibitor of hepatitis C virus NS3/4A protease Edith Monteagudo, Massimiliano Fonsi, Xiaoyan Chu, Xenobiotica	2010	17

Page 1